Drugs / umbilical cord blood unit (CBU)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02508324 | Sep 2015 → Jun 2022 | acute myeloid leukemia, myelodysplastic syndrome | Weill Medical College of Cornell University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord blood unit (CBU) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02508324 ↗ |
| Modality | Cell therapy | “We conducted a prospective evaluation of cord blood (CB)-derived adoptive cell therapy, after salvage chemotherapy, for patients with advanced myeloid malignancies and poor prognosis.” PMID 33091124 ↗ Oct 2020 |